Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)

China · Delayed Price · Currency is CNY

3.610

+0.040 (1.12%)

Nov 2, 2026, 3:04 PM CST

SHE:002524 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Revenue	813.73	885.18	892.84	1,075	767.44	1,044
Revenue Growth	-5.11%	-0.86%	-16.94%	40.06%	-26.52%	13.40%
Gross Profit	320.46	319.26	326.24	374.86	190.55	332.4
Operating Income	42.86	28.6	-6.15	36.83	-93.26	5.99
Net Income	2.98	-19.5	-174.65	9.26	-78.22	36.93
Earnings Per Share	0.01	-0.04	-0.34	0.02	-0.15	0.07
EPS Growth	-	-	-	-	-	-12.50%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Medical and Health Sector	758.62	778.3
Steel Structure Plate	101.09	79.19
Energy Sector	25.48	35.36
Total	885.18	892.84

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Investments	49.08	48.65	67.69	91.06	65.41	89.32
Total Debt	718.83	760.13	840.18	890.26	827.42	794.74
Net Cash (Debt)	-669.75	-711.48	-772.49	-799.19	-762.01	-705.41
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.30	-1.46	-1.50	-1.73	-1.46	-1.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Cash Flow	149.57	124.73	69.07	38.91	124.33	145.37
Capital Expenditures	-19.14	-29.04	-25.75	-23.42	-40.71	-52.47
Free Cash Flow	130.43	95.69	43.32	15.48	83.61	92.91
Free Cash Flow Growth	176.95%	120.89%	179.81%	-81.48%	-10.00%	0.01%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Gross Margin	39.38%	36.07%	36.54%	34.87%	24.83%	31.82%
Operating Margin	5.27%	3.23%	-0.69%	3.43%	-12.15%	0.57%
Pretax Margin	3.20%	-0.19%	-18.04%	0.74%	-9.85%	4.30%
Profit Margin	0.37%	-2.20%	-19.56%	0.86%	-10.19%	3.54%
FCF Margin	16.03%	10.81%	4.85%	1.44%	10.90%	8.89%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
PE Ratio	622.41	-	-	358.19	-	127.23
Forward PE	-	43.56	43.56	43.56	43.56	43.56
P/FCF Ratio	14.16	22.02	43.24	214.13	43.67	50.57
PS Ratio	2.27	2.38	2.10	3.08	4.76	4.50